These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19944363)

  • 1. Long-term effects of dietary sodium intake on cytokines and neurohormonal activation in patients with recently compensated congestive heart failure.
    Parrinello G; Di Pasquale P; Licata G; Torres D; Giammanco M; Fasullo S; Mezzero M; Paterna S
    J Card Fail; 2009 Dec; 15(10):864-73. PubMed ID: 19944363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
    Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?
    Paterna S; Gaspare P; Fasullo S; Sarullo FM; Di Pasquale P
    Clin Sci (Lond); 2008 Feb; 114(3):221-30. PubMed ID: 17688420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term effects of dietary sodium restriction on clinical outcomes in patients with heart failure. The SODIUM-HF (Study of Dietary Intervention Under 100 mmol in Heart Failure): a pilot study.
    Colin-Ramirez E; McAlister FA; Zheng Y; Sharma S; Armstrong PW; Ezekowitz JA
    Am Heart J; 2015 Feb; 169(2):274-281.e1. PubMed ID: 25641537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study).
    Paterna S; Fasullo S; Parrinello G; Cannizzaro S; Basile I; Vitrano G; Terrazzino G; Maringhini G; Ganci F; Scalzo S; Sarullo FM; Cice G; Di Pasquale P
    Am J Med Sci; 2011 Jul; 342(1):27-37. PubMed ID: 21701268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
    Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G
    J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive fluid and sodium restriction in acute decompensated heart failure: a randomized clinical trial.
    Aliti GB; Rabelo ER; Clausell N; Rohde LE; Biolo A; Beck-da-Silva L
    JAMA Intern Med; 2013 Jun; 173(12):1058-64. PubMed ID: 23689381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure.
    Mitrovic V; Willenbrock R; Miric M; Seferovic P; Spinar J; Dabrowski M; Kiowski W; Marks DS; Alegria E; Dukát A; Lenz K; Arens HA
    Am Heart J; 2003 Mar; 145(3):E14. PubMed ID: 12660683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diet with usual quantity of salt in hospital treatment of congestive heart insufficiency].
    Velloso LG; Alonso RR; Ciscato CM; Barretto AC; Bellotti G; Pileggi F
    Arq Bras Cardiol; 1991 Dec; 57(6):465-8. PubMed ID: 1824218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurohormonal and inflammatory markers as predictors of short-term outcome in patients with heart failure and cardiac resynchronization therapy.
    Glick A; Michowitz Y; Keren G; George J
    Isr Med Assoc J; 2006 Jun; 8(6):391-5. PubMed ID: 16833167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to a sodium-restricted diet is associated with lower symptom burden and longer cardiac event-free survival in patients with heart failure.
    Son YJ; Lee Y; Song EK
    J Clin Nurs; 2011 Nov; 20(21-22):3029-38. PubMed ID: 21707808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma n-3 polyunsaturated fatty acids in chronic heart failure in the GISSI-Heart Failure Trial: relation with fish intake, circulating biomarkers, and mortality.
    Masson S; Marchioli R; Mozaffarian D; Bernasconi R; Milani V; Dragani L; Tacconi M; Marfisi RM; Borgese L; Cirrincione V; Febo O; Nicolis E; Maggioni AP; Tognoni G; Tavazzi L; Latini R
    Am Heart J; 2013 Feb; 165(2):208-15.e4. PubMed ID: 23351824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of dietary sodium intervention effect on neurohormonal and fluid overload in heart failure patients: Review of select research based literature.
    Lee YW; Huang LH; Ku CH
    Appl Nurs Res; 2018 Aug; 42():17-21. PubMed ID: 30029710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence with once daily versus twice daily carvedilol in patients with heart failure: the Compliance And Quality of Life Study Comparing Once-Daily Controlled-Release Carvedilol CR and Twice-Daily Immediate-Release Carvedilol IR in Patients with Heart Failure (CASPER) Trial.
    Udelson JE; Pressler SJ; Sackner-Bernstein J; Massaro J; Ordronneau P; Lukas MA; Hauptman PJ
    J Card Fail; 2009 Jun; 15(5):385-93. PubMed ID: 19477398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term biventricular resynchronisation therapy in advanced heart failure: effect on neurohormones.
    Braun MU; Rauwolf T; Zerm T; Schulze M; Schnabel A; Strasser RH
    Heart; 2005 May; 91(5):601-5. PubMed ID: 15831642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered sodium intake affects plasma concentrations of BNP but not proBNP in healthy individuals and patients with compensated heart failure.
    Damgaard M; Goetze JP; Norsk P; Gadsbøll N
    Eur Heart J; 2007 Nov; 28(22):2726-31. PubMed ID: 17942579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes.
    Comín-Colet J; Ruiz S; Cladellas M; Rizzo M; Torres A; Bruguera J
    J Card Fail; 2009 Nov; 15(9):727-35. PubMed ID: 19879457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction.
    Udelson JE; Bilsker M; Hauptman PJ; Sequeira R; Thomas I; O'Brien T; Zimmer C; Orlandi C; Konstam MA
    J Card Fail; 2011 Dec; 17(12):973-81. PubMed ID: 22123358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.